Non disclosure of complementary medicine use a persistent issue in senior oncology patients

The persistent issue of senior oncology patients not disclosing the complementary medicines they are taking has prompted a call for “greater engagement of pharmacists to reduce drug-related problems and unnecessary medications”. In a report published in the Journal of Geriatric Oncology, US researchers performed a comprehensive review of all of the medications taken by senior oncology patients and found that more than 26 percent were using complementary or alternative medicines (CAM).

To continue reading this article, please Log In or Sign Up for access.